Exact Mass: 443.1117

propaquizafop

C22H22ClN3O5 (443.1248)

CONFIDENCE standard compound; EAWAG_UCHEM_ID 122 Propaquizafop is a phenoxyisopropionic acid herbicide and an acetyl-coA carboxylase inhibitor[1][2].

Dihydrofolic acid

C19H21N7O6 (443.1553)

Dihydrofolic acid is a folic acid derivative acted upon by dihydrofolate reductase to produce tetrahydrofolic acid. It interacts with bacteria during cell division. It can be targeted with drug analogs to prevent nucleic acid synthesis. Dihydrofolic acid is also known by the name Dihydrofolate - more commonly Vitamin B9. [HMDB] Dihydrofolic acid is a folic acid derivative acted upon by dihydrofolate reductase to produce tetrahydrofolic acid. It interacts with bacteria during cell division. It can be targeted with drug analogs to prevent nucleic acid synthesis. Dihydrofolic acid is also known by the name Dihydrofolate - more commonly Vitamin B9. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Dihydrofolic acid is a folic acid derivative acted upon by dihydrofolate reductase to produce tetrahydrofolic acid.

3-O-acetyl-4-O-demethylpapaveroxine

C23H25NO8 (443.158)

CID 9980845

C24H21N5O4 (443.1593)

Fumiquinazoline C

C24H21N5O4 (443.1593)

A fumiquinazoline obtained by oxidative spirocyclisation of fumiquinazoline A.

LY2874455

C21H19Cl2N5O2 (443.0916)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor

3'-Azido-3'-deoxy-5'- O-beta-D-glucopyranuronosylthymidine

C16H21N5O10 (443.1288)

3-Azido-3-deoxy-5- O-beta-D-glucopyranuronosylthymidine is a metabolite of zidovudine. Zidovudine or azidothymidine (AZT) (also called ZDV) is a nucleoside analog reverse-transcriptase inhibitor (NRTI), a type of antiretroviral drug used for the successful treatment of HIV/AIDS infectiousness. It is a therapeutic analog of thymidine. AZT is the first U.S. government-approved treatment for HIV therapy, prescribed under the names Retrovir and Retrovis. (Wikipedia)

N-debutylhalofantrine

C22H22Cl2F3NO (443.103)

N-debutylhalofantrine is a metabolite of halofantrine. Halofantrine is a drug used to treat malaria. Halofantrines structure contains a substituted phenanthrene, and is related to the antimalarial drugs quinine and lumefantrine. Marketed as Halfan, halofantrine is never used to prevent malaria and its mode of action is unknown. A crystallographic study have shown that halofantrine binds to hematin in vitro, suggesting a possible mechanism of action. (Wikipedia) D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents

2-(4-(((2-Amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)methyl)amino)benzamido)pentanedioic acid

C19H21N7O6 (443.1553)

Tetramethylrhodamine isothiocyanate

C25H21N3O3S (443.1304)

D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D012235 - Rhodamines D004396 - Coloring Agents > D005456 - Fluorescent Dyes

Clofluperol

C22H22ClF4NO2 (443.1275)

C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

Fasidotril

C23H25NO6S (443.1403)

p-Nitrophenyl thymidine 5'-monophosphate

C16H18N3O10P (443.073)

(4-{2-[(4-Carbamimidoyl-benzoyl)-methyl-amino]-acetyl}-2-carboxymethoxy-phenoxy)-acetic acid

C21H21N3O8 (443.1329)

Selinexor

C17H11F6N7O (443.0929)

Zidovudine glucuronide

C16H21N5O10 (443.1288)

D009676 - Noxae > D000963 - Antimetabolites > D015224 - Dideoxynucleosides

fumiquinazoline D

C24H21N5O4 (443.1593)

4-O-Desmethyl-3-O-acetylpapaveroxine

C23H25NO8 (443.158)

CCG-44885

C18H22ClN3O4S2 (443.074)

Maybridge4_002048

C23H25NO4S2 (443.1225)

MCULE-9549881617

C24H21N5O4 (443.1593)

MCULE-8152080646

C17H10F9N3O (443.068)

L-Tyrosine benzyl ester 4-toluenesulfonate

C23H25NO6S (443.1403)

(13S,14R)-13-O-acetyl-1,8-dihydroxy-N-methylcanadine

C23H25NO8 (443.158)

Oxytetracycline Impurity C

C23H25NO8 (443.158)

aristolactam F|aristolactam-AIIIa-6-O-beta-D-glucoside

C22H21NO9 (443.1216)

oxalatrunculin B

C20H29NO8S (443.1614)

yorophenzine

C20H17N3O7S (443.0787)

lamellarin O1

C26H21NO6 (443.1369)

aristololactam GZ1

C26H21NO6 (443.1369)

Nitrile,2-O-[beta-D-xylopyranosyl-(1鈥樏傗垎6)-beta-D-glucopyranoside]-2-Hydroxy-2-(3-hydroxyphenyl)acetic acid

C19H25NO11 (443.1428)

Narceimin

C22H21NO9 (443.1216)

Tyr Met Met

C19H29N3O5S2 (443.1549)

Moricizine sulfoxide

C22H25N3O5S (443.1515)

Met Met Tyr

C19H29N3O5S2 (443.1549)

Met Tyr Met

C19H29N3O5S2 (443.1549)

NCGC00380154-01!

C24H21N5O4 (443.1593)

C24H21N5O4_2,17-Dimethyl-1,9a-dihydro-3H,16H-spiro[imidazo[1,2-a]indole-9,14-[13]oxa[2,10,17]triazatetracyclo[10.3.2.0~2,11~.0~4,9~]heptadeca[4,6,8,10]tetraene]-3,3,16(2H)-trione

C24H21N5O4 (443.1593)

C24H21N5O4_(1S,3S,12S,14R,27S)-12-Hydroxy-1,3-dimethyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1~2,5~.0~6,11~.0~12,27~.0~15,24~.0~17,22~]heptacosa-6,8,10,17,19,21,23-heptaene-4,16,26-trione (Fumiquinazoline C)

C24H21N5O4 (443.1593)

C24H21N5O4_(1S,3S,12S,14R,27S)-12-Hydroxy-1,3-dimethyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1~2,5~.0~6,11~.0~12,27~.0~15,24~.0~17,22~]heptacosa-6,8,10,17,19,21,23-heptaene-4,16,26-trione

C24H21N5O4 (443.1593)

[IIN-based on: CCMSLIB00000845724]

C24H21N5O4 (443.1593)

[IIN-based: Match]

C24H21N5O4 (443.1593)

Dihydrofolate

C19H21N7O6 (443.1553)

Dihydrofolic acid is a folic acid derivative acted upon by dihydrofolate reductase to produce tetrahydrofolic acid.

Ala Cys His Asn

C16H25N7O6S (443.1587)

Ala Cys Asn His

C16H25N7O6S (443.1587)

Ala His Cys Asn

C16H25N7O6S (443.1587)

Ala His Asn Cys

C16H25N7O6S (443.1587)

Ala Asn Cys His

C16H25N7O6S (443.1587)

Ala Asn His Cys

C16H25N7O6S (443.1587)

Cys Ala His Asn

C16H25N7O6S (443.1587)

Cys Ala Asn His

C16H25N7O6S (443.1587)

Cys Gly His Gln

C16H25N7O6S (443.1587)

Cys Gly Gln His

C16H25N7O6S (443.1587)

Cys His Ala Asn

C16H25N7O6S (443.1587)

Cys His Gly Gln

C16H25N7O6S (443.1587)

Cys His Asn Ala

C16H25N7O6S (443.1587)

Cys His Gln Gly

C16H25N7O6S (443.1587)

Cys Asn Ala His

C16H25N7O6S (443.1587)

Cys Asn His Ala

C16H25N7O6S (443.1587)

Cys Gln Gly His

C16H25N7O6S (443.1587)

Cys Gln His Gly

C16H25N7O6S (443.1587)

Gly Cys His Gln

C16H25N7O6S (443.1587)

Gly Cys Gln His

C16H25N7O6S (443.1587)

Gly His Cys Gln

C16H25N7O6S (443.1587)

Gly His Gln Cys

C16H25N7O6S (443.1587)

Gly Gln Cys His

C16H25N7O6S (443.1587)

Gly Gln His Cys

C16H25N7O6S (443.1587)

His Ala Cys Asn

C16H25N7O6S (443.1587)

His Ala Asn Cys

C16H25N7O6S (443.1587)

His Cys Ala Asn

C16H25N7O6S (443.1587)

His Cys Gly Gln

C16H25N7O6S (443.1587)

His Cys Asn Ala

C16H25N7O6S (443.1587)

His Cys Gln Gly

C16H25N7O6S (443.1587)

His Gly Cys Gln

C16H25N7O6S (443.1587)

His Gly Gln Cys

C16H25N7O6S (443.1587)

His Asn Ala Cys

C16H25N7O6S (443.1587)

His Asn Cys Ala

C16H25N7O6S (443.1587)

His Gln Cys Gly

C16H25N7O6S (443.1587)

His Gln Gly Cys

C16H25N7O6S (443.1587)

Asn Ala Cys His

C16H25N7O6S (443.1587)

Asn Ala His Cys

C16H25N7O6S (443.1587)

Asn Cys Ala His

C16H25N7O6S (443.1587)

Asn Cys His Ala

C16H25N7O6S (443.1587)

Asn His Ala Cys

C16H25N7O6S (443.1587)

Asn His Cys Ala

C16H25N7O6S (443.1587)

Gln Cys Gly His

C16H25N7O6S (443.1587)

Gln Cys His Gly

C16H25N7O6S (443.1587)

Gln Gly Cys His

C16H25N7O6S (443.1587)

Gln Gly His Cys

C16H25N7O6S (443.1587)

Gln His Cys Gly

C16H25N7O6S (443.1587)

Gln His Gly Cys

C16H25N7O6S (443.1587)

Zidovudine glucuronide

C16H21N5O10 (443.1288)

D009676 - Noxae > D000963 - Antimetabolites > D015224 - Dideoxynucleosides

Desmethylhalofantrine

C22H22Cl2F3NO (443.103)

Met-Trp-OH

C21H21N3O6S (443.1151)

KRP 203

C24H26ClNO3S (443.1322)

2-[-N-(2-cyanoethyl)-4-[(p-nitrophenyl)azo]anilino]ethyl benzoate

C24H21N5O4 (443.1593)

1H-Pyrazole-4-carboxamide, N-[5-[(cyclopropylamino)carbonyl]-2-Methylphenyl]-5-Methyl-1-[3-(trifluoromethyl)-2-pyridinyl]-

C22H20F3N5O2 (443.1569)

[3-(2-Chloro-6-fluorophenyl)-5-methyl-1,2-oxazol-4-yl][4-(2-ethox yphenyl)-1-piperazinyl]methanone

C23H23ClFN3O3 (443.1412)

(S)-1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-N-METHYLETHANAMINE 4-METHYLBENZENESULFONATE

C18H19F6NO3S (443.099)

Flumeridone

C22H23ClFN5O2 (443.1524)

C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent

AOP

C11H21F6N7OP2 (443.1187)

H-Tyr-ObzlTos

C23H25NO6S (443.1403)

CGP 54626 hydrochloride

C18H29Cl3NO3P (443.0951)

benzyl 2-amino-3-(4-hydroxyphenyl)propanoate,4-methylbenzenesulfonic acid

C23H25NO6S (443.1403)

tritc

C25H21N3O3S (443.1304)

2-[[4-[[4-[bis(2-hydroxyethyl)amino]-6-chloro-1,3,5-triazin-2-yl]amino]phenyl]azo]-p-cresol

C20H22ClN7O3 (443.1473)

Solvent Red 210

C26H22ClN3O2 (443.14)

(Z)-2-(2-Tritylaminothiazol-4-yl)-2-methoxyiminoacetic acid

C25H21N3O3S (443.1304)

Tetramethylrhodamine-5-isothiocyanate

C25H21N3O3S (443.1304)

fmoc-l-3-benzothienylalanine

C26H21NO4S (443.1191)

Aceclofenac Benzyl Ester

C23H19Cl2NO4 (443.0691)

Disperse Orange 73

C24H21N5O4 (443.1593)

2-Acetyl-2-decarboxamidooxytetracycline

C23H25NO8 (443.158)

[2-(benzylcarbamoyl)-4-(2,4-difluorophenyl)phenyl] benzoate

C27H19F2NO3 (443.1333)

[4-(2,4-difluorophenyl)-2-[(2-methylphenyl)carbamoyl]phenyl] benzoate

C27H19F2NO3 (443.1333)

[4-(2,4-difluorophenyl)-2-[(3-methylphenyl)carbamoyl]phenyl] benzoate

C27H19F2NO3 (443.1333)

[4-(2,4-difluorophenyl)-2-[(4-methylphenyl)carbamoyl]phenyl] benzoate

C27H19F2NO3 (443.1333)

fumoxicillin

C21H21N3O6S (443.1151)

C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

Selinexor

C17H11F6N7O (443.0929)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

OSI-930

C22H16F3N3O2S (443.0915)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

Fmoc-D-3-Benzothienylalanine

C26H21NO4S (443.1191)

5-BroMo-7-[trans-4-(tert-butyldiMethylsilanyloxy)cyclohexyl]-2-chloro-7H-pyrrolo[2,3-d]pyriMidine

C18H27BrClN3OSi (443.0795)

Fasidotril

C23H25NO6S (443.1403)

N-Deshydroxyethyl Dasatinib

C20H22ClN7OS (443.1295)

1H-Indole-2-carboxamide, 5-chloro-N-((1S)-1-((4-fluorophenyl)methyl)-2-(4-hydroxy-1-piperidinyl)-2-oxoethyl)-

C23H23ClFN3O3 (443.1412)

D004791 - Enzyme Inhibitors

N-[2-({[amino(Imino)methyl]amino}oxy)ethyl]-2-{6-Chloro-3-[(2,2-Difluoro-2-Phenylethyl)amino]-2-Fluorophenyl}acetamide

C19H21ClF3N5O2 (443.1336)

(E)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N-(pyrazin-2-yl)acrylohydrazide

C17H11F6N7O (443.0929)

p-Nitrophenyl thymidine 5-monophosphate

C16H18N3O10P (443.073)

rac-3-hydroxy-N,N-dimethylcoclaurinium trifluoroacetate

C21H24F3NO6 (443.1556)

A natural product found in Gnetum montanum.

(2S)-2-[(4-{[(2-amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}benzoyl)amino]pentanedioate

C19H21N7O6-2 (443.1553)

COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

3-(2-chlorophenyl)-5-methyl-N-[3-(3-methyl-2-imidazo[1,2-a]pyrimidinyl)phenyl]-4-isoxazolecarboxamide

C24H18ClN5O2 (443.1149)

(2E,NZ)-N-(6-acetamido-3-(2-ethoxyethyl)benzo[d]thiazol-2(3H)-ylidene)-3-(2-chlorophenyl)acrylamide

C22H22ClN3O3S (443.107)

(2E)-N-Allyl-4-{[3-(4-bromophenyl)-5-fluoro-1-methyl-1H-indazol-6-YL]oxy}-N-methyl-2-buten-1-amine

C22H23BrFN3O (443.1008)

5-O-(L-prolylsulfamoyl)adenosine

C15H21N7O7S (443.1223)

2-(2-Chloro-4-Fluorophenoxy)-2-Methyl-N-[(1r,2s,3s,5s,7s)-5-(Methylsulfonyl)-2-Adamantyl]propanamide

C21H27ClFNO4S (443.1333)

2,17-Dimethylspiro[13-oxa-2,10,17-triazatetracyclo[10.3.2.02,11.04,9]heptadeca-4,6,8,10-tetraene-14,4-3,3a-dihydro-2H-imidazo[1,2-a]indole]-1,3,16-trione

C24H21N5O4 (443.1593)

Ethyl-[10-(3-morpholin-4-ylpropanoyl)-5-oxophenothiazin-2-yl]carbamic acid

C22H25N3O5S (443.1515)

(2S,3S,4S,5R)-6-[[(2S)-3-azido-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C16H21N5O10 (443.1288)

(2s)-4-[{[(2s,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydrofuran-2-Yl]methyl}(Carboxylatomethyl)sulfonio]-2-Ammoniobutanoate

C16H23N6O7S+ (443.1349)

(6S)-5,6,7,8-tetrahydrofolate(2-)

C19H21N7O6-2 (443.1553)

CMP-5-3-(aminopropyl)phosphonate

C12H21N4O10P2- (443.0733)

4-(5,6-dihydroxy-1H-indol-2-yl)-2-(5,6-dihydroxy-1H-indol-7-yl)-1H-indole-5,6-diol

C24H17N3O6 (443.1117)

2,4:2,4-Ter(1H-indole-5,6-diol)

C24H17N3O6 (443.1117)

5-Hydroxy-a-6-deoxytetracycline

C22H23N2O8- (443.1454)

2,4-bis(5,6-dihydroxy-1H-indol-2-yl)-1H-indole-5,6-diol

C24H17N3O6 (443.1117)

(E)-phenyl-[(1S,3S,6R,8R,9S)-1,3,8,10-tetrahydroxy-9-(4-methoxy-6-oxopyran-2-yl)-4-oxo-5-oxatricyclo[4.3.1.03,8]decan-2-ylidene]methanolate

C22H19O10- (443.0978)

N-(3-acetylphenyl)-2-[[6-chloro-3-(2-hydroxypropyl)-4-methyl-2-oxo-1-benzopyran-7-yl]oxy]acetamide

C23H22ClNO6 (443.1136)

4-(Dimethylamino)benzoic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

C25H21N3O3S (443.1304)

2-[[1-[(3-chlorophenyl)methyl]-3-indolyl]sulfonyl]-N-(5-methyl-3-isoxazolyl)acetamide

C21H18ClN3O4S (443.0706)

ethyl 2-[(4E)-4-[[4-(2-methoxy-2-oxoethoxy)phenyl]methylidene]-3-methyl-5-oxopyrazol-1-yl]-4-methyl-1,3-thiazole-5-carboxylate

C21H21N3O6S (443.1151)

4-[[2-[(1,1-Dioxo-3-thiolanyl)amino]-2-oxoethyl]thio]-2,5-dimethyl-6-thieno[2,3-d]pyrimidinecarboxylic acid ethyl ester

C17H21N3O5S3 (443.0643)

N-(1,2-dihydroacenaphthylen-5-yl)-2-[[6-hydroxy-1-(4-methylphenyl)-4-oxo-2-pyrimidinyl]thio]acetamide

C25H21N3O3S (443.1304)

Bis(1-ethenyl-2-imidazolyl)-(9-ethyl-3-carbazolyl)-sulfanylidenephosphorane

C24H22N5PS (443.1333)

1-[4-Ethoxy-3-[[[4-(2-oxolanylmethyl)-5-thiophen-2-yl-1,2,4-triazol-3-yl]thio]methyl]phenyl]ethanone

C22H25N3O3S2 (443.1337)

methyl 5-[1-amino-8,8-dimethyl-5-(morpholin-4-yl)-8,9-dihydro-6H-pyrano[4,3-d]thieno[2,3-b]pyridin-2-yl]furan-2-carboxylate

C22H25N3O5S (443.1515)

N-[3-[4-[(2-methoxyphenyl)sulfamoyl]anilino]-3-oxopropyl]-2-furancarboxamide

C21H21N3O6S (443.1151)

N-butan-2-yl-6-[(4-ethoxyphenyl)sulfamoyl]-4-oxo-1H-quinoline-3-carboxamide

C22H25N3O5S (443.1515)

N-(5-chloro-2,4-dimethoxyphenyl)-1-methyl-4-(4-morpholinylsulfonyl)-2-pyrrolecarboxamide

C18H22ClN3O6S (443.0918)

N-(1,1-dioxo-3-thiolanyl)-N-methyl-2-[[1-(2-phenylethyl)-2-benzimidazolyl]thio]acetamide

C22H25N3O3S2 (443.1337)

N-[5-(1-azepanylsulfonyl)-2-chlorophenyl]-2-[(4-methyl-1,2,4-triazol-3-yl)thio]acetamide

C17H22ClN5O3S2 (443.0853)

1-(2-furanyl)-N-[[1-[(4-methylphenyl)sulfonylmethyl]-5-tetrazolyl]methyl]-N-(thiophen-2-ylmethyl)methanamine

C20H21N5O3S2 (443.1086)

4-bromo-N-[(2,8-dimethyl-3,4,4a,9b-tetrahydro-1H-pyrido[4,3-b]indol-5-yl)-sulfanylidenemethyl]benzamide

C21H22BrN3OS (443.0667)

N-(1,3-benzodioxol-5-ylmethyl)-3-methoxy-N-[(4-oxo-1H-quinazolin-2-yl)methyl]benzamide

C25H21N3O5 (443.1481)

3-L-prolyl-AMP(1-)

C15H20N6O8P- (443.108)

An organophosphate oxoanion obtained by deprotonation of the phosphate OH groups and protonation of the amino group of 3-L-prolyl-AMP; major species at pH 7.3.

N-[[1-[2-[2-chloro-5-(trifluoromethyl)anilino]-2-oxoethyl]-4-triazolyl]methyl]cyclohexanecarboxamide

C19H21ClF3N5O2 (443.1336)

N-[[(2R,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide

C18H26BrN3O5 (443.1056)

N-[[(2S,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide

C18H26BrN3O5 (443.1056)

N-[[(2R,3R)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide

C18H26BrN3O5 (443.1056)

(1S,4aS,11S,11aS,12aS)-3-carbamoyl-1-(dimethylazaniumyl)-4a,7,11-trihydroxy-11-methyl-4,6-dioxo-1,4,4a,6,11,11a,12,12a-octahydrotetracene-2,5-diolate

C22H23N2O8- (443.1454)

(1S,9R,10R,11R)-12-[(3-chlorophenyl)methyl]-10-(hydroxymethyl)-11-(morpholine-4-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

C23H26ClN3O4 (443.1612)

(1R,9S,10S,11S)-12-[(3-chlorophenyl)methyl]-10-(hydroxymethyl)-11-(morpholine-4-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

C23H26ClN3O4 (443.1612)

N-[[(2R,3S)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide

C18H26BrN3O5 (443.1056)

N-[[(2R,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide

C18H26BrN3O5 (443.1056)

N-[[(2S,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide

C18H26BrN3O5 (443.1056)

N-[[(2S,3S)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide

C18H26BrN3O5 (443.1056)

N-[[(2S,3R)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide

C18H26BrN3O5 (443.1056)

Met-Met-Tyr

C19H29N3O5S2 (443.1549)

Tyr-Met-Met

C19H29N3O5S2 (443.1549)

Met-Tyr-Met

C19H29N3O5S2 (443.1549)

2-[[4-[(2-amino-4-oxo-5,6,7,8-tetrahydro-3H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioate

C19H21N7O6-2 (443.1553)

(6R)-5,6,7,8-tetrahydrofolyl-(gamma-L-Glu)n

C19H21N7O6-2 (443.1553)

Dihydrofolic acid

C19H21N7O6 (443.1553)

A folic acid derivative acted upon by dihydrofolate reductase to produce tetrahydrofolic acid. It interacts with bacteria during cell division and is targeted by various drugs to prevent nucleic acid synthesis. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Dihydrofolic acid is a folic acid derivative acted upon by dihydrofolate reductase to produce tetrahydrofolic acid.

3-O-acetyl-4-O-demethylpapaveroxine

C23H25NO8 (443.158)

A benzylisoquinoline alkaloid that is 8-hydroxy-2-methyl-6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline which is substituted at the 1-pro-R position by an (acetyloxy)(2-formyl-3,4-dimethoxyphenyl)methyl group. An intermediate in the biosynthesis of noscarpine in the opium poppy, Papaver somniferum.

(6S)-5,6,7,8-tetrahydrofolate(2-)

C19H21N7O6 (443.1553)

Dianion of (6S)-5,6,7,8-tetrahydrofolic acid arising from deprotonation of both carboxylic acid functions.

2-(4-(((2-Amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)methyl)amino)benzamido)pentanedioic acid

C19H21N7O6 (443.1553)

5,6,7,8-tetrahydrofolate(2-)

C19H21N7O6 (443.1553)

A dicarboxylic acid anion arising from deprotonation of both carboxylic acid functions of 5,6,7,8-tetrahydrofolic acid; major structure at pH 7.3

tetracycline(1-)

C22H23N2O8 (443.1454)

An organic anion that is the conjugate base of tetracycline obtained by deprotonation of the two enolic hydroxy groups and protonation of the tertiary amino group.

S-adenosyl-S-carboxymethyl-L-homocysteine

C16H23N6O7S (443.1349)

A sulfonium compound that is S-adenosyl-L-methionine in which one of the methyl hydrogens has been replaced by a carboxy group.

ST 18:3;O5;Tau

C20H29NO8S (443.1614)

MK-8617

C24H21N5O4 (443.1593)

MK-8617 is an orally active pan-inhibitor of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) with an IC50 of 1 nM for PHD2.

QNZ46

C24H17N3O6 (443.1117)

QNZ46 is a NR2C/NR2D-selective NMDA receptor non-competitive antagonist (IC50 values are 3, 6, 229, and >300, >300 μM for NR2D, NR2C, NR2A, NR2B, and GluR1, respectively). IC50 value: 3 μM (for NR2D), 6 μM (for NR2C), 229 μM (for NR2D NR2A) Target: NR2D, NR2C, NR2A in vitro: QNZ46 is a noncompetitive inhibitor of GluN2C/D containing NMDA receptors. KD and IC50 values for binding and inhibition of GluN1/Glun2D receptors by QNZ46 are 4.9 and 3.9 μM, respectively. QNZ46 does not compete for binding of glutamate or glycine, but QNZ46 receptor binding requires the binding of glutamate to the GluN2 subunit.

methyl 4-[(1-{10-acetyl-11,13-dihydroxy-2,12-dimethyl-3,5-dioxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),6,9,11-tetraen-4-ylidene}ethyl)amino]butanoate

C23H25NO8 (443.158)

(1r,3s,12s,14r,27r)-12,26-dihydroxy-1,3-dimethyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1²,⁵.0⁶,¹¹.0¹⁵,²⁴.0¹⁷,²².0¹²,²⁷]heptacosa-6,8,10,17,19,21,23,25-octaene-4,16-dione

C24H21N5O4 (443.1593)

4-{[(2s)-2-[(1-hydroxyethylidene)amino]-3-methoxy-3-oxopropyl]sulfanyl}phenazine-1,6-dicarboxylic acid

C20H17N3O7S (443.0787)

(11r,15r,17r)-4-hydroxy-5-[(2r,4r,5s,6r)-5-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraene-2,9,13-trione

C23H25NO8 (443.158)

4-({2-[(1-hydroxyethylidene)amino]-3-methoxy-3-oxopropyl}sulfanyl)phenazine-1,6-dicarboxylic acid

C20H17N3O7S (443.0787)

1-acetyl-6-[4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-5-hydroxy-3-methylnaphtho[2,3-c]thiophene-4,9-dione

C23H25NO6S (443.1403)

(1's,2s,9s,9as,12'r)-2,17'-dimethyl-2,9a-dihydro-1h-13'-oxa-2',10',17'-triazaspiro[imidazo[1,2-a]indole-9,14'-tetracyclo[10.3.2.0²,¹¹.0⁴,⁹]heptadecane]-4',6',8',10'-tetraene-3,3',16'-trione

C24H21N5O4 (443.1593)

aristololactam GI

C26H21NO6 (443.1369)

{"Ingredient_id": "HBIN016819","Ingredient_name": "aristololactam GI","Alias": "NA","Ingredient_formula": "C26H21NO6","Ingredient_Smile": "CC1C(OC2=C(O1)C=C3C4=C2C5=CC=CC=C5C=C4NC3=O)C6=CC(=C(C(=C6)OC)O)OC","Ingredient_weight": "443.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35617","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "71573773","DrugBank_id": "NA"}

(1'r,2s,9s,9as,12's)-16'-hydroxy-2,12'-dimethyl-2,9a-dihydro-1h-13'-oxa-2',10',17'-triazaspiro[imidazo[1,2-a]indole-9,14'-tetracyclo[10.3.2.0²,¹¹.0⁴,⁹]heptadecane]-4',6',8',10',16'-pentaene-3,3'-dione

C24H21N5O4 (443.1593)

12,26-dihydroxy-1,3-dimethyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1²,⁵.0⁶,¹¹.0¹⁵,²⁴.0¹⁷,²².0¹²,²⁷]heptacosa-6,8,10,17,19,21,23,25-octaene-4,16-dione

C24H21N5O4 (443.1593)

2,17'-dimethyl-2,9a-dihydro-1h-13'-oxa-2',10',17'-triazaspiro[imidazo[1,2-a]indole-9,14'-tetracyclo[10.3.2.0²,¹¹.0⁴,⁹]heptadecane]-4',6',8',10'-tetraene-3,3',16'-trione

C24H21N5O4 (443.1593)

(9's,9'ar)-9'-hydroxy-9'-{[(4s)-3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-1',9'a-dihydrospiro[cyclopropane-1,2'-imidazo[1,2-a]indol]-3'-one

C24H21N5O4 (443.1593)

2-acetyl-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,11-dione

C23H25NO8 (443.158)

2-({11,14-dihydroxy-15-methoxy-10-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2(7),3,5,8,10,12,14-octaen-4-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C22H21NO9 (443.1216)

1-acetyl-6-[(2r,4r,5s,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-5-hydroxy-3-methylnaphtho[2,3-c]thiophene-4,9-dione

C23H25NO6S (443.1403)

(1s,3s,12s,14r,27s)-12,26-dihydroxy-1,3-dimethyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1²,⁵.0⁶,¹¹.0¹⁵,²⁴.0¹⁷,²².0¹²,²⁷]heptacosa-6,8,10,17,19,21,23,25-octaene-4,16-dione

C24H21N5O4 (443.1593)

16'-hydroxy-2,12'-dimethyl-2,9a-dihydro-1h-13'-oxa-2',10',17'-triazaspiro[imidazo[1,2-a]indole-9,14'-tetracyclo[10.3.2.0²,¹¹.0⁴,⁹]heptadecane]-4',6',8',10',16'-pentaene-3,3'-dione

C24H21N5O4 (443.1593)

(2s)-2-(3-hydroxyphenyl)-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}acetonitrile

C19H25NO11 (443.1428)

(1r,3s,12s,14r,27s)-12,26-dihydroxy-1,3-dimethyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1²,⁵.0⁶,¹¹.0¹⁵,²⁴.0¹⁷,²².0¹²,²⁷]heptacosa-6,8,10,17,19,21,23,25-octaene-4,16-dione

C24H21N5O4 (443.1593)

methyl 4-({1-[(2r,4e)-10-acetyl-11,13-dihydroxy-2,12-dimethyl-3,5-dioxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),6,9,11-tetraen-4-ylidene]ethyl}amino)butanoate

C23H25NO8 (443.158)

(2s,3r,4s,5s,6r)-2-({11,14-dihydroxy-15-methoxy-10-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2(7),3,5,8,10,12,14-octaen-4-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C22H21NO9 (443.1216)

(1'r,2s,9s,9as,12'r)-16'-hydroxy-2,12'-dimethyl-2,9a-dihydro-1h-13'-oxa-2',10',17'-triazaspiro[imidazo[1,2-a]indole-9,14'-tetracyclo[10.3.2.0²,¹¹.0⁴,⁹]heptadecane]-4',6',8',10',16'-pentaene-3,3'-dione

C24H21N5O4 (443.1593)

(4s,4as,5as,6s,12as)-2-acetyl-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,11-dione

C23H25NO8 (443.158)

9'-hydroxy-9'-({3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl}methyl)-1',9'a-dihydrospiro[cyclopropane-1,2'-imidazo[1,2-a]indol]-3'-one

C24H21N5O4 (443.1593)

(1'r,2s,9s,9ar,12'r)-16'-hydroxy-2,12'-dimethyl-2,9a-dihydro-1h-13'-oxa-2',10',17'-triazaspiro[imidazo[1,2-a]indole-9,14'-tetracyclo[10.3.2.0²,¹¹.0⁴,⁹]heptadecane]-4',6',8',10',16'-pentaene-3,3'-dione

C24H21N5O4 (443.1593)